Skip to main content


Log in

Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease

Atherogener Plasma-Index könnte ein starker Prädiktor für subklinische Atherosklerose bei Patienten mit M. Behçet sein

  • Originalien
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript



Behcet’s disease (BD) is a systemic vasculitis characterized by cardiovascular complications. Early diagnosis of these complications can reduce morbidity and mortality. Carotid artery intima–media thickness (cIMT) and the logarithmic value of triglyceride to high density lipoprotein ratio (atherogenic index of plasma, AIP) are good markers of atherosclerosis. The purpose of this study was to investigate whether AIP is a predictive marker of subclinical atherosclerosis in BD patients.

Patients and methods

A total of 84 BD patients (60 male, 24 female) and 84 healthy control individuals (58 male, 26 female) were included in this study. cIMT measurements were made, and AIP values were calculated.


cIMT (p < 0.001) and AIP (p < 0.001) values of the BD patients were higher than those of the control group. A strong independent relationship was found between the AIP value and cIMT (β = 0.232, p = 0.018). In the subgroup analysis, the cIMT and AIP values of male BD patients were higher than those of female BD patients.


Increased AIP and cIMT values can be a good marker for subclinical atherosclerosis in BD patients, especially in male BD patients.



Bei Morbus Behçet („Behcet’s disease“, BD) handelt es sich um eine systemische Vaskulitis, die durch kardiovaskuläre Komplikationen charakterisiert ist. Eine frühzeitige Diagnose dieser Komplikationen kann die Morbidität und Mortalität reduzieren. Die Intima-Media-Dicke der A. carotis (cIMT) und der Logarithmus aus dem Quotienten aus Triglyceriden und Lipoproteinen mit hoher Dichte (atherogener Plasma-Index, AIP) sind geeignete Marker für eine Atherosklerose. Ziel dieser Studie war es, zu untersuchen, ob der AIP ein prädiktiver Marker für eine subklinische Atheroskerlose bei BD-Patienten ist.

Patienten und Methoden

Insgesamt 84 BD-Patienten (60 männlich, 24 weiblich) und 84 gesunde Kontrollpersonen (58 männlich, 26 weiblich) wurden in diese Studie eingeschlossen. Es wurden Messungen der cIMT vorgenommen und die AIP-Werte berechnet.


Die cIMT- (p < 0,001) und AIP-Werte (p < 0,001) der BD-Patienten waren höher als die der Kontrollgruppe. Es wurde eine starke unabhängige Beziehung zwischen dem AIP- und dem cIMT-Wert festgestellt (β = 0,232, p = 0,018). In der Subgruppenanalyse waren die cIMT- und AIP-Werte der männlichen BD-Patienten höher als die der weiblichen.


Erhöhte AIP- und cIMT-Werte können einen geeigneten Marker für die subklinische Atherosklerose bei BD-Patienten, insbesondere bei männlichen Patienten, darstellen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others


  1. Desbois AC, Wechsler B, Cluzelc P et al (2014) Cardiovascular involvement in Behcet’s disease. Rev Med Inter 35:103–111

    Article  Google Scholar 

  2. Kural-Seyahi E, Fresko I, Seyahi N et al (2014) The long-term mortality and morbidity of Behcet syndrome: a 2‑decade outcome survey of 387 patients followed at a dedicated center. Cardiology 129:203–206

    Google Scholar 

  3. Moran AE, Forouzanfar MH, Roth GA et al (2014) The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation 129:1493–1501

    Article  PubMed  PubMed Central  Google Scholar 

  4. Di Angelantonio E, Sarwar N, Perry P (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993–2000

    Article  PubMed  Google Scholar 

  5. Sacks FM, Ridker PM (1999) Lipid Lowering and beyond: results from the CARE study on lipoproteins and inflamamation. Cholesterol and Recurrent Events. Herz 24:51–56

    Article  CAS  PubMed  Google Scholar 

  6. Seyahi E, Ugurlu S, Cumali R et al (2008) Atherosclerosis in Behçet’s Syndrome. Semin Arthritis Rheum 38:1–12

    Article  CAS  PubMed  Google Scholar 

  7. Ozuguz P, Karabulut AA, Tulmac M et al (2014) Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behcet disease. Angiology 65:937–943

    Article  PubMed  Google Scholar 

  8. Keser G, Aksu K, Tamsel S et al (2005) Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behçet’s disease. Clin Exp Rheumatol 23:71–76

    Google Scholar 

  9. Icli A, Cure E, Cure MC et al (2016) Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet’s disease. J Investig Med 64:875–881

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nwagha UI, Ikekpeazu EJ, Ejezie FE et al (2010) Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci 10:248–252

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Mudhaffar SK (2013) Atherogenic index of plasma (AIP) as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratios). Karbala J Med 6:1506–1513

    Google Scholar 

  12. Grover SA, Levington C, Paquet S (1999) Identifying adults at low risk fora significant hyperlipidemia: a validated clinical index. J Clin Epidemiol 52:49–55

    Article  CAS  PubMed  Google Scholar 

  13. Han SH, Nicholls SJ, Sakuma I et al (2016) Hypertriglyceridemia and cardiovascular diseases: revisited. Korean Circ J 46:135–144

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shapiro MD, Fazio S (2016) From lipids to inflammation: new approaches to reducing atherosclerotic risk. Circ Res 118:732–749

    Article  CAS  PubMed  Google Scholar 

  15. Onat A, Can G, Kaya H et al (2010) Atherogenic index of plasma (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 4:89–98

    Article  PubMed  Google Scholar 

  16. Bhakta BB, Brennan P, James TE et al (1999) Behcet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatol 38:728–733

    Article  CAS  Google Scholar 

  17. Krause I, Mader R, Sulkes J et al (2001) Behçet’s disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 28:1033–1036

    CAS  PubMed  Google Scholar 

  18. International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080

    Google Scholar 

  19. Benedetto FA, Mallamaci F, Tripepi G et al (2001) Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 12:2458–2464

    CAS  PubMed  Google Scholar 

  20. Icli A, Cure E, Cure MC et al (2015) Endocan levels and subclinical atherosclerosis in patients with systemic lupus Erythematosus. Angiology doi:10.1177/0003319715616240

    Google Scholar 

  21. Beşir FH, Yazgan S, Celbek G et al (2015) Normal value correlates of carotid intima-media thickness and affecting parameters in healthy adults. Anadolu Kardiyol Derg 12:427–433

    Google Scholar 

  22. Lim TK, Lim E, Dwivedi G et al (2008) Normal value of Carotid intima-media thickness – a surrogate marker of atherosclerosis: quantitative assessment by B‑mode carotid ultrasound. J Am Soc Echocardiogr 21:112–116

    Article  PubMed  Google Scholar 

  23. Ozturk C, Balta S, Balta I et al (2015) Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with Behçet disease without cardiovascular involvement. Angiology 66:291–296

    Article  PubMed  Google Scholar 

  24. Merashli M, Ster IC, Ames PR (2016) Subclinical atherosclerosis in Behcet’s disease: a systematic review and meta-analysis. Semin Arthritis Rheum 45:502–510

    Article  PubMed  Google Scholar 

  25. Rodriguez-Carballeira M, Alba MA, Solans-Laque R et al (2014) REGEB investigators. Registry of the Spanish network of Behçet’s disease: a descriptive analysis of 496 patients. Clin Exp Rheumatol 32:33–39

    Google Scholar 

  26. Franklin BA, Cushman M (2011) Recent advances in preventive cardiology and lifestyle medicine: a themed series. Circulation 123:2274–2283

    Article  PubMed  Google Scholar 

  27. Zhao B, Liu Y, Zhang Y et al (2012) Gender difference in carotid intima-media thickness in type 2 diabetic patients: a 4‑year follow-up study. Cardiovasc Diabetol 11:51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kablak-Ziembicka A, Przewlocki T, Tracz W et al (2005) Gender differences in carotid intima-media thickness in patients with suspected coronary artery disease. Am J Cardiol 96:1217–1222

    Article  PubMed  Google Scholar 

  29. Sarac I, Backhouse K, Shojaee-Moradie F et al (2012) Gender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men. J Clin Endocrinol Metab 97:2475–2481

    Article  CAS  PubMed  Google Scholar 

  30. Krauss RM (2004) Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27:1496–1504

    Article  CAS  PubMed  Google Scholar 

  31. Boizel R, Benhamou PY, Lardy B et al (2000) Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 23:1679–1685

    Article  CAS  PubMed  Google Scholar 

  32. Cure MC, Cure E, Tufekci A et al (2013) Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Ann Indian Acad Neurol 16:498–503

    Article  PubMed  PubMed Central  Google Scholar 

  33. Gaal K, Tarr T, Lorincz H, Borbas V et al (2016) High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids Health Dis 15:60

    Article  PubMed  PubMed Central  Google Scholar 

  34. Rosvall M, Persson M, Östling G et al (2015) Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study. Atherosclerosis 239:615–621

    Article  CAS  PubMed  Google Scholar 

  35. Soska V, Jarkovsky J, Ravcukova B et al (2012) The logarithm of the triglyceride/HDL-cholesterol ratio is related to the history of cardiovascular disease in patients with familial hypercholesterolemia. Clin Biochem 45:96–100

    Article  CAS  PubMed  Google Scholar 

  36. Dobiasova M (2006) AIP – atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek 52:64–71

    CAS  PubMed  Google Scholar 

  37. Acartürk E, Cayli M, Akpinar O et al (2004) Relation between age and gender differences in plasma triglyceride concentrations and coronary artery disease in Southern Turkey. Clin Chim Acta 339:123–128

    Article  PubMed  Google Scholar 

  38. Stensland-Bugge E, Bonaa KH, Joakimsen O et al (2000) Sex differences in the relationship of risk factors to subclinical carotid atherosclerosis measured 15 years later: the Tromso study. Stroke 31:574–581

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to E. Cure.

Ethics declarations

Conflict of interest

E. Cure, A. Icli, A. Ugur Uslu, R. Aydoğan Baykara, D. Sakiz, M. Ozucan, F. Yavuz, S. Arslan, M. Cumhur Cure, and A. Kucuk declare that they have no competing interests.

The study was approved by the Ethics Committee of Necmettin Erbakan University, Meram Medical Faculty, and all participants gave written and verbal informed consent consistent with the Helsinki Declaration.

Additional information


U. Müller-Ladner, Bad Nauheim

U. Lange, Bad Nauheim

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cure, E., Icli, A., Ugur Uslu, A. et al. Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease. Z Rheumatol 76, 259–266 (2017).

Download citation

  • Published:

  • Issue Date:

  • DOI: